China National Accord Medicines Corporation Ltd.’s Net Profit Rose 16% in 2022

China National Accord Medicines Corporation Ltd. (国药集团一致药业股份有限公司) (000028.SZ) reported a net profit of 1.8 billion yuan in 2022, up 16% year-on-year.

Meanwhile, the company posted 73.4 billion yuan in revenue, up 7.4% year-on-year.

At the end of the reporting period, it had 42.6 billion yuan in total assets and 23.2 billion yuan in total liabilities, with a liability-to-asset ratio of 54.4%.